What you’ll learn:
Results of Tandem’s RCT on using Control-IQ+ technology with type 2 diabetes
How Control-IQ+ supports the use of simplified bolusing strategies to simplify insulin management
The additive impact of AID for patients living with type 2 diabetes using GLP-1 medications